Phosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entry

Molecular and Cellular Biology

Volumn 26, Issue 23, 2006, Pages 9116-9125

  Kumar, Amit ^a   Marqués, Miriam ^a   Carrera, Ana C ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MINICHROMOSOME MAINTENANCE PROTEIN 2; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN RAS KINASE; PROTEIN TYROSINE KINASE; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CHROMATIN; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME INHIBITION; FUNCTIONAL PROTEOMICS; GENE INDUCTION; GENETIC STABILITY; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL CULTURE TECHNIQUES; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; ENZYME ACTIVATION; G1 PHASE; MICE; NIH 3T3 CELLS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; RAS PROTEINS; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; S PHASE;

EID: 33845226377     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00783-06     Document Type: Article

References (43)

1. Alvarez, B., A. C. Martinez, B. M. Burgering, and A. C. Carrera. 2001. Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature 413:744-747.
2. Álvarez, B., F. Garrido, J. A. Garcia-Sanz, and A. C. Carrera. 2003. Phosphoinositide 3-kinase activation regulates cell division time by coordinated control of cell mass and cell cycle progression rate. J. Biol. Chem. 278:26466-26473.
3. Amati, B., K. Alevizopoulos, and J. Vlach. 1998. Myc and the cell cycle. Front. Biosci. 3:250-268.
4. Blow, J. J., and A. Dutta. 2005. Preventing re-replication of chromosomal DNA. Nat. Rev. Mol. Cell Biol. 6:476-486.
5. Bouchard, C., J. Marquardt, A. Bras, R. H. Medema, and M. Eilers. 2004. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J. 23:2830-2840.
6. Chan, T. O., U. Rodeck, A. M. Chan, A. C. Kimmelman, S. E. Rittenhouse, G. Panayotou, and P. N. Tsichlis. 2002. Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit. Cancer Cell 1:181-191.
7. Coverley, D., H. Laman, and R. A. Laskey. 2002. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat. Cell Biol. 4:523-528.
8. Cvetic, C. A., and J. C. Walter. 2006. Getting a grip on licensing: mechanism of stable Mcm2-7 loading onto replication origins. Mol. Cell 21:143-144.
9. Dang, C. V. 1999. c-Myc target genes involved in cell growth, apoptosis and metabolism. Mol. Cell. Biol. 19:1-11.
10. del Real, G., S. Jimenez-Baranda, E. Mira, R. A. Lacalle, P. Lucas, C. Gomez-Mouton, M. Alegret, J. M. Pena, M. Rodriguez-Zapata, M. Alvarez-Mon, A. C. Martinez, and S. Manes. 2004. Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med. 200:541-547.
11. Ekholm-Reed, S., J. Mendez, D. Tedesco, A. Zetterberg, B. Stillman, and S. I. Reed. 2004. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J. Cell Biol. 165:789-800.
12. Garcia, Z., A. Kumar, M. Marques, I. Cortes, and A. C. Carrera. 2006. Phospho-inositide 3-kinase controls early and late events in mammalian cell division. EMBO J. 25:655-661,
13. Geng, Y., Q. Yu., E. Sicinska, M. Das, J. E. Schneider, S. Bhattacharya, W. M. Rideout, R. T. Bronson, H. Gardner, and P. Sicinski. 2003. Cyclin E ablation in the mouse. Cell 114:431-443.
14. Hemann, M. T., A. Bric, J. Teruya-Feldstein, A. Herbst, J. A. Nilsson, C. Cordon-Cardo, J. L. Cleveland, W. P. Tansey, and S. W. Lowe. 2005. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436:807-811.
15. Jiménez, C., C. Hernandez, B. Pimentel, and A. C. Carrera. 2002. The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. J. Biol. Chem. 277:41556-41562.
16. Jirmanova, L., M. Afanassieff, S. Gobert-Gosse, S. Markossian, and P. Savatier. 2002. Differential contributions of ERK and PI3K to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse ES cells. Oncogene 21:5515-5528.
17. Jones, S. M., and A. Kazlauskas. 2001. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat. Cell Biol. 3:165-172.
18. Jones, S. M., R. Klinghoffer, G. D. Prestwich, A. Toker, and A. Kazlauskas. 1999. PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1. Curr. Biol. 9:512-521.
19. Klippel, A., M. A. Escobedo, M. S. Wachowicz, G. Apell, T. W. Brown, M. A. Giedlin, W. N. Kavanaugh, and L. T. Williams. 1998. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol. 18:5699-56711.
20. Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
21. Madine, M. A., M. Swietlik, C. Pelizon, P. Romanowski, A. D. Mills, and R. A. Laskey. 2000. The roles of the MCM, ORC, and Cdc6 proteins in determining the replication competence of chromatin in quiescent cells. J. Struct. Biol. 129:198-210.
22. 2 mRNA expression by forkhead transcription factors: a novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol. Cell. Biol. 24:2181-2189.
23. Mateyak, M. K., A. J. Obaya, S. Adachi, and J. M. Sedivy. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1039-1048.
24. Mateyak, M. K., A. J. Obaya, and J. M. Sedivy. 1999. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol. 19:4672-4683.
25. kip1. Nature 404:782-787.
26. Méndez, J., and B. Stillman. 2002. Chromatin association of human origin recognition complex, Cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol. 20:8602-8612.
27. Nishitani, H., and Z. Lygerou. 2002. Control of DNA replication licensing in a cell cycle. Genes Cells 7:523-534.
28. Pelengaris, S., M. Khan, and G. Evan. 2002. c-MYC more than just a matter of life and death. Nat. Rev. Cancer 2:764-776.
29. Kip1 binding to newly formed complexes. Oncogene 14:2373-2381.
30. Ponzielli, R., S. Katz, D. Barsyte-Lovejoy, and L. Z. Penn. 2005. Cancer-therapeutics: targeting the dark side of Myc. Eur. J. Cancer 41:2485-2501.
31. Ryves, W. J., and A. J. Harwood. 2003. The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle. Prog. Cell Cycle Res. 5:489-495.
32. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
33. Schmidt, M., S. Fernandez de Mattos, A. van der Horst, R. Klompmaker, G. J. Kops, E. W. Lam, B. M. Burgering, and R. H. Medema. 2002. Cell cycle inhibition by FoxO transcription factors involves downregulation of cyclin D. Mol. Cell. Biol. 22:7842-7852.
34. Schorl, C., and J. M. Sedivy. 2003. Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point. Mol. Biol. Cell 14:823-835.
35. INK4a. Cell 88:593-602.
36. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
37. Kip1 at threonine 157 and modulation of its cellular localization. Nat. Med. 8:1145-1152.
38. Stacey, D., and A. Kazlauskas. 2002. Regulation of Ras signaling by the cell cycle. Curr. Opin. Genet. Dev. 12:44-46.
39. Taylor, C. C. 2000. Platelet-derived growth factor activates porcine thecal cell PI3K-Akt/PKB and Ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-β receptor. Endocrinology 141:1545-1553.
40. Uckun, F. M., R. K. Narla, T. Zeren, Y. Yanishevski, D. E. Myers, B. Waurzyniak, O. Ek, E. Schneider, Y. Messinger, L. M. Chelstrom, R. Gunther, and W. Evans. 1998. In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor. Clin. Cancer Res. 4:1125-1134.
41. Van Weeren, P. C., K. M. de Bruyn, A. M. de Vries-Smits, J. van Lint, and B. M. Burgering. 1998. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J. Biol. Chem. 273:13150-13156.
42. Kip1 is abrogated by c-Myc. EMBO J. 15:6595-6604.
43. Yeh, E., M. Cunningham, H. Arnold, D. Chasse, T. Monteith, G. Ivaldi, W. C. Hahn, P. T. Stukenberg, S. Shenolikar, T. Uchida, C. M. Counter, J. R. Nevins, A. R. Means, and R. A. Sears. 2004. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6:308-318.